SSR 19-4p in 2026: How Social Security Evaluates Migraine, Cluster, and Tension-Type Headaches, Why Listing 11.02 Is the Anchor, and What Your File Has to Show to Win on Medical Equivalence

By Anthony Albert, Benefits Research Director · Published June 15, 2026 · 15 min read

Primary headache disorder is the most misdiagnosed disabling condition at Social Security. Not because adjudicators do not believe headaches are real, but because they sit in a strange spot in the Blue Book. There is no listing for migraine. There is no listing for cluster headache. There is no listing for chronic tension-type headache. And yet thousands of people every year win SSDI and SSI cases on headaches alone. The bridge they use is SSR 19-4p.

SSR 19-4p has been the controlling rule on primary headache disorders since August 26, 2019. SSA has not rescinded it. Adjudicators still apply it word for word in 2026. If you have severe migraines or cluster headaches and you want a disability finding, you need to understand what this ruling demands and what your medical file actually has to look like on the day the ALJ opens it.

What primary headache disorder means at SSA

SSA uses the International Classification of Headache Disorders, 3rd edition (ICHD-3), as the medical reference for primary headache types. ICHD-3 splits primary headaches into four families:

• Migraine (with or without aura, chronic migraine, vestibular migraine)
• Tension-type headache (episodic and chronic)
• Trigeminal autonomic cephalalgias (cluster headache, paroxysmal hemicrania, SUNCT, hemicrania continua)
• Other primary headache disorders (primary cough, primary exercise, primary stabbing, hypnic, new daily persistent)

The word "primary" matters. Primary headache means the headache is the disease, not a symptom of something else. Headaches caused by tumors, trauma, vascular malformations, medication overuse, or infection are secondary headaches and get evaluated under whatever underlying listing fits the cause. SSR 19-4p is the rule for the primary group only.

If you have post-concussive headaches after a traumatic brain injury, the analysis can still use SSR 19-4p by analogy, but the underlying TBI gets evaluated under Listings 11.18 (cerebral trauma), 12.02 (neurocognitive disorder), or both. Many real cases run both tracks at once.

The MDI gate: what your records must establish

Before any equivalence question is on the table, SSA has to find that you have a medically determinable impairment, or MDI. Under SSR 19-4p, a diagnosis alone is not enough. A symptom report from the patient is not enough. The ruling sets four evidentiary anchors that an acceptable medical source (AMS) must address. The AMS is usually a licensed physician or, in many states, a licensed advanced practice nurse or physician assistant. A neurologist or headache specialist is preferred but not required.

Here are the four anchors SSR 19-4p lists:

1. A primary headache diagnosis after exclusion of other causes. The AMS has to document a history, physical exam, and exclusion of secondary causes. That usually means brain MRI or CT, sometimes lumbar puncture, sometimes vascular imaging. Your file should show those negative workups.
2. An observation of a typical headache event by the AMS, or a credible third-party observation. If your neurologist saw you mid-attack and described it in a note, that hits the bar. If a family member, school nurse, employer, or ER physician described an attack, that can substitute. The observation has to be detailed: where the pain is, how long it lasts, what triggers it, what makes it worse, what you can and cannot do during the attack.
3. Remarkable or unremarkable findings on laboratory tests. The phrasing is intentional. Negative MRIs and CTs are evidence in your favor on a primary headache claim because they rule out secondary causes. SSA will not purchase imaging just to evaluate headaches, so your file has to bring those records.
4. Response to treatment. Documented headaches that persist despite a real treatment regimen are stronger than headaches with sketchy treatment history. The ruling rewards consistent neurologist follow-up, trials of multiple preventive medications, abortive therapy logs, and documented side effects.

If your file is missing the AMS observation piece, you can patch it with detailed third-party statements. A spouse statement that says "Maria gets two to three attacks a week, she goes into a dark room for four to six hours, she throws up almost every time, she cannot use a screen the day after" is real evidence the ALJ can credit. ALJs cite third-party statements all the time in headache cases.

Why Listing 11.02 is the anchor

SSR 19-4p tells adjudicators that the most analogous listing for primary headache disorder is Listing 11.02, epilepsy. That is the central insight of the ruling. Headaches and seizures look nothing alike clinically, but they share a critical feature for disability analysis: discrete, episodic events that completely interrupt a person's ability to function for a measurable period of time. That structural similarity is what makes the equivalence work.

Listing 11.02 has four paragraphs, A through D. SSR 19-4p focuses on paragraphs B and D, because those are the ones built around dyscognitive seizures, which behave most like severe headache attacks.

To equal 11.02B on headaches, you need attack frequency of roughly once a week or more for at least three months in a row, despite treatment. To equal 11.02D, the bar is once every two weeks for three months, plus a marked limitation in one of these five functional domains, which mirror the 12.00 mental listings:

• Physical functioning
• Understanding, remembering, or applying information
• Interacting with others
• Concentrating, persisting, or maintaining pace
• Adapting or managing oneself (which SSA breaks into the subcategories of physical function and adapting to change)

"Marked" is the second-highest rating SSA uses, sitting between "moderate" and "extreme." It means the limitation seriously interferes with the ability to function independently, appropriately, and effectively on a sustained basis. In practice, marked limitation is what you get when a person needs to stop and rest for several hours, multiple times a week, in a dark and quiet space.

How adjudicators count attack frequency

This is where most cases die. ALJs need a clean record of attack frequency. Memory and estimates are not enough. SSR 19-4p tells adjudicators to look at:

• Headache diaries kept by the claimant
• Office notes that record attack frequency at each visit
• Medication refill patterns for triptans, gepants, ditans, ergots
• ER visit logs for status migrainosus or intractable headache
• Botox treatment notes, CGRP injection records, and other procedural records

If a claimant is filling 18 sumatriptan tablets a month, that is direct evidence of at least 18 abortive treatments in a month. If a claimant gets Botox every 12 weeks under the PREEMPT protocol for chronic migraine, that establishes a clinician's working diagnosis of 15 or more headache days a month, of which 8 or more have migraine features. Those numbers are persuasive.

The treatment-compliance trap

Under SSR 19-4p, the equivalence to 11.02 only works if the headaches persist despite adherence to prescribed treatment. That phrase does heavy lifting in denials. Adjudicators will look for gaps in compliance and use them to deny.

Three counter-arguments work in real cases:

1. Side effects are documented. If you stopped topiramate because it caused word-finding problems, your neurologist's note saying so satisfies the rule. SSR 18-3p (failure to follow prescribed treatment) controls here, and it gives clear shelter for documented side effects.
2. Cost or access barriers are documented. CGRP monoclonal antibodies cost about $700 a month at list price. Even with insurance, copays and step therapy delays are real. POMS DI 24515.012 lets adjudicators credit non-compliance tied to ability to afford treatment.
3. You tried it and it failed. Failed trials are not non-compliance. Document every trial, the duration, the dose, and the reason for discontinuation. Your medication list should read like a war diary.

The RFC track when equivalence fails

Even if you cannot meet or equal 11.02, SSR 19-4p still controls the RFC analysis. RFC is the residual functional capacity, the most you can still do despite your impairments. For headaches the RFC fight comes down to three numbers the vocational expert (VE) will treat as case-killing:

If your RFC includes either three or more absences per month or 15 percent or more off-task time, the VE will testify that no competitive employment exists. That is a Step 5 win. SSR 24-3p (vocational expert testimony) reinforced this in 2024 by giving ALJs cleaner standards for how to credit VE evidence on off-task and absence limitations.

Cluster headaches: a special case

Cluster headache is a trigeminal autonomic cephalalgia. The pain is described in the medical literature as among the most severe a human can experience. Attacks last 15 minutes to 3 hours, occur 1 to 8 times a day, and cluster into bouts that can last weeks or months. Between bouts there can be long pain-free remission periods.

SSR 19-4p applies the same 11.02 analogy to cluster headache. The frequency math is friendlier here. A patient with active cluster bouts often has 3 to 6 attacks daily for 6 to 12 weeks at a time. Inside a bout, 11.02B is easy to clear. The issue at SSA is durability. ALJs ask whether the cluster pattern is expected to last 12 months or longer at listing-level severity.

Chronic cluster (no remission longer than 3 months in a 12-month span) clears that durational test. Episodic cluster with predictable annual bouts often clears it too, especially when each bout disables the claimant for 6 to 8 weeks at a stretch.

The 2026 procedural updates that matter

SSR 19-4p has not been amended since 2019, but two procedural rules tightened how it gets applied:

• SSR 16-3p (subjective symptom evaluation) tells the ALJ to weigh consistency between the claimant's reports and the medical record. For headache claims this means your symptom testimony has to line up with the medication record, ER record, and neurologist's note. Inconsistencies sink credibility findings fast.
• 20 CFR 404.1520c (medical opinion persuasiveness) rewrote how ALJs weigh treating-source opinions. Treating neurologists no longer get automatic deference, but a well-supported headache disability opinion from a treating headache specialist with consistent visit notes is still extraordinarily persuasive under the supportability and consistency prongs.

If your neurologist will fill out a headache RFC questionnaire that maps directly to the 11.02 frequency and functional criteria, get one signed and dated. ALJs cite those questionnaires in favorable decisions almost universally.

The five-step worked example

How to apply this rule to your case

Read your file with these questions in mind:

1. Does an acceptable medical source diagnose a primary headache disorder by name (chronic migraine, episodic cluster headache, chronic tension-type headache)?
2. Has the AMS documented exclusion of secondary causes through imaging and clinical workup?
3. Is there a third-party or AMS observation of a typical headache event?
4. Do the records show a treatment history with multiple failed or partially effective trials of preventive and abortive medications?
5. Does the record document attack frequency at a level that maps to 11.02B (weekly) or 11.02D (every two weeks plus marked functional limitation)?
6. If equivalence fails, is the RFC supported by evidence of 3 or more absences per month or 15 percent or more off-task time?

If you answer yes to 1, 2, 3, 4, and 5, you have a meet-or-equal case. If you answer yes to 1, 2, 3, 4, and 6 but not 5, you have a strong Step 5 RFC case. If you cannot answer yes to 1 and 2, you do not have a case yet. You have a documentation project.

The most common reasons headache cases lose

• No headache specialist in the file. PCP-only management makes frequency claims hard to credit.
• No headache diary. Claimants who say "I have a lot of headaches" get downgraded on credibility.
• Inconsistent medication history. Refill records that show only sporadic triptan use undermine high-frequency reports.
• Single negative imaging study with no follow-up neurology notes.
• No third-party statements when the AMS has not observed an attack.
• Treatment compliance gaps without documented side effects or access issues.

Every one of these is fixable before the hearing. The headache RFC questionnaire, the third-party statement template, and the medication trial log are the three documents that turn most weak cases into winnable ones.

Bottom line

SSR 19-4p is the most important rule for migraine and cluster headache claims at Social Security. It says: headaches are not listed, but they can equal Listing 11.02 if the frequency, treatment history, and functional impact line up with the dyscognitive-seizure analogy. The case is won on the medical file, not on testimony.

If your headaches are bad enough that you cannot work a normal job, the medical evidence has to look the part. See If You Qualify and we will help you map your records to SSR 19-4p before SSA does it for you.

Related reading

• Listing 11.02 epilepsy frequency requirements
• Migraine disability benefits overview
• Medical equivalence under 20 CFR 404.1526
• SSR 16-3p subjective symptom evaluation
• SSR 24-3p vocational expert testimony
• Medical opinion persuasiveness under 20 CFR 404.1520c

Frequently asked questions